CALRETICULIN (CALR) Gene Mutations in Myeloproliferative Neoplasms

View Test

Carnitine Palmitoyltransferase 1A (CPT1A) Deficiency

  • Test Code:
    1160
  • Department:
  • Test Synonyms:
    Carnitine Palmitoyltransferase 1A
View Test

Catecholaminergic Polymorphic Ventricular Tachycardia Panel

  • Test Code:
    1167
  • Department:
  • Test Synonyms:
    Ventricular Tachycardia CPVT ANK2 CALM1 CASQ2 KCNJ2 RYR2 TRDN
View Test

CEBPA Mutation Testing in Acute Myeloid Leukemia (AML)

View Test

CEP X and CEP Y FISH

View Test

Charcot-Marie-Tooth Syndrome Panel

  • Test Code:
    1035
  • Department:
  • Test Synonyms:
    Neuromuscular disorders Peripheral neuropathy Hereditary motor/sensory neuropathy AARS BSCL2 DCTN1 DNAJB2 DNM2 DYNC1H1 EGR2 FGD4 FIG4 GARS GDAP1 GJB1 HSPB1 HSPB8 IGHMBP2 KIF1B LITAF LMNA LRSAM1 MED25 MFN2 MPZ MTMR2 NDRG1 NEFL PMP22 PRPS1 PRX RAB7A SBF2 SH3TC2 SPTLC1 TRPV4 YARS
View Test

Childhood Epilepsy Panel

  • Test Code:
    1290
  • Department:
  • Test Synonyms:
    Infantile Epilepsy Epilepsy/Seizures Juvenile myoclonic epilepsy ADSL CACNB4 CDKL5 CHRNA2 CHRNA4 CHRNB2 CLN3 CLN5 CLN6 CLN8 CNTNAP2 CSTB CTSD EFHC1 EPM2A FOLR1 FOXG1 GABRA1 GABRG2 GAMT GATM GOSR2 GRIN2A KCTD7 LGI1 MAGI2 MBD5 MECP2 MEF2C MFSD8 NHLRC1 NRXN1 PNKP POLG PPT1 PRICKLE1 SCN1A SCN1B SCN2A SLC2A1 SLC9A6 SYN1 TBC1D24 TCF4 TPP1 UBE3A WDR45 ZEB2
View Test

Cholestasis Panel

  • Test Code:
    1275
  • Department:
  • Test Synonyms:
    Intrahepatic cholestasis Citrin deficiency Alagille syndrome ABCB4 AKR1D1 ATP8B1 JAG1 SLC25A13
View Test

Chorionic Villus Sampling: Full Chromosome Analysis

  • Test Code:
    6100
  • Department:
  • Test Synonyms:
    Chorionic Villus Study CVS Chromosomal Analysis Chromosome Analysis, Chorionic Villi Chorionic Villus Sampling Chromosomes
View Test

Chromosomal Microarray - Postnatal

  • Test Code:
    6500
  • Department:
  • Test Synonyms:
    Array comparative genomic hybridization aCGH Microarray Competitive genomic hybridization Chromosome microarray Postnatal
View Test

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More